发明名称 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
摘要 The present invention relates to novel linear and cyclic polypeptides that bind to IL-23 receptor and inhibit the binding of IL-23 to its corresponding receptor and cell signaling thereof. The novel polypeptides of the present invention has a core structure of WX1X2X3W, where W is tryptophan, and X1, X2 and X3 are amino acids, with the proviso that when one of X1, X2 or X3 is W, the remaining two of X1, X2 or X3 cannot be W. Preferred core structures include WVDYW or WQDYW. The present invention relates a composition containing the novel polypeptides (linear or cyclic), and use of same in inhibiting cell functions including production of IL-22 and IL-17F from immune cells as well as in treating IL-23 associated human diseases including, for example, inflammatory bowel diseases, psoriasis and Crohn's disease, ulcerative colitis and multiple sclerosis.
申请公布号 US9605027(B2) 申请公布日期 2017.03.28
申请号 US201514922630 申请日期 2015.10.26
申请人 Medical Diagnostic Laboratories, LLC 发明人 Gallagher Grant;Yu Raymond;Brazaitis Jonathan
分类号 C07K7/64;C07K7/06;H04N1/10;C07K14/435;A61K38/12;A61K38/00;H04N1/193 主分类号 C07K7/64
代理机构 代理人 Lo Siu K.
主权项 1. An isolated cyclic polypeptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 177, SEQ ID NO: 178 and SEQ ID NO: 179, wherein said isolated cyclic polypeptide inhibits binding of IL-23 to IL-23 receptor and inhibits IL-23-mediated cell signaling.
地址 Hamilton NJ US